Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-19-037522
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-17 19:05:57
Reporting Period:
2019-06-14
Accepted Time:
2019-06-17 19:05:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1636050 Axovant Gene Therapies Ltd. AXGT Pharmaceutical Preparations (2834) 981333697
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1643071 Atul Pande C/o Axovant Gene Therapies Ltd.
11 Times Square, 33Rd Floor
New York NY 10036
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-14 3,370 $5.22 3,370 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct